ASRT - Assertio Holdings Inc
IEX Last Trade
1.18
0.020 1.695%
Share volume: 245,923
Last Updated: Fri 30 Aug 2024 09:55:15 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$1.16
0.02
1.72%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-08 | 2023-03-08 | 2023-05-09 | 2023-08-09 | 2023-11-08 | 2024-03-11 | 2024-05-06 | |
| Assets | |||||||||
| Total Assets | 321.976 M | 323.344 M | 413.913 M | 414.274 M | 405.179 M | 380.028 M | 286.419 M | 281.965 M | |
| Current Assets | 116.692 M | 126.494 M | 132.262 M | 137.849 M | 133.549 M | 184.960 M | 171.062 M | 172.474 M | |
| Inventories | 12.259 M | 14.268 M | 13.696 M | 16.226 M | 18.817 M | 42.710 M | 37.686 M | 38.602 M | |
| Other Current Assets | 3.632 M | 2.720 M | 8.268 M | 6.554 M | 2.949 M | 2.895 M | 12.272 M | 10.519 M | |
| Short Term Investments | 3.632 M | 2.720 M | 8.268 M | 6.554 M | 2.949 M | 2.895 M | 12.272 M | 10.519 M | |
| Total Receivables | 48.537 M | 44.680 M | 45.357 M | 46.466 M | 41.608 M | 62.467 M | 47.663 M | 42.610 M | |
| Current Cash | 52.264 M | 64.826 M | 64.941 M | 68.603 M | 70.175 M | 76.888 M | 73.441 M | 80.743 M | |
| Total Non-current Assets | 205.284 M | 196.850 M | 281.651 M | 276.425 M | 271.630 M | 195.068 M | 115.357 M | 109.491 M | |
| Property Plant Equipment | 1.133 M | 935.000 K | 744.000 K | 544.000 K | 877.000 K | 804.000 K | 770.000 K | 704.000 K | |
| Other Assets | 2.559 M | 2.457 M | 2.304 M | 2.493 M | 2.409 M | 2.189 M | 1.986 M | 1.852 M | |
| Intangible Assets | 199.585 M | 191.617 M | 197.996 M | 191.712 M | 185.428 M | 170.413 M | 111.332 M | 105.701 M | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 19.856 M | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 321.976 M | 323.344 M | 413.913 M | 414.274 M | 405.179 M | 380.028 M | 286.419 M | 281.965 M | |
| Total liabilities | 193.607 M | 188.429 M | 188.188 M | 163.610 M | 150.908 M | 187.155 M | 148.416 M | 147.471 M | |
| Total current liabilities | 116.150 M | 92.296 M | 95.316 M | 94.545 M | 79.478 M | 114.289 M | 93.443 M | 92.444 M | |
| Accounts Payable | 9.415 M | 8.374 M | 5.991 M | 6.173 M | 11.182 M | 19.004 M | 13.439 M | 15.650 M | |
| Other liabilities | 27.957 M | 30.151 M | 26.469 M | 30.914 M | 33.179 M | 34.000 M | 14.989 M | 15.056 M | |
| Current long term debt | 11.662 M | 2.175 M | 470.000 K | 470.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 49.500 M | 65.982 M | 66.403 M | 38.151 M | 38.251 M | 38.866 M | 38.514 M | 38.621 M | |
| Other liabilities | 27.957 M | 30.151 M | 26.469 M | 30.914 M | 33.179 M | 34.000 M | 14.989 M | 15.056 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 128.369 M | 134.915 M | 225.725 M | 250.664 M | 254.271 M | 192.873 M | 138.003 M | 134.494 M | |
| Common stock | 46.274 M | 48.180 M | 48.358 M | 51.005 M | 56.142 M | 81.713 M | 95.264 M | 94.980 M | |
| Retained earnings | -412.328 M | -408.154 M | -319.601 M | -323.085 M | -314.615 M | -594.159 M | -651.543 M | -656.053 M |